2025 WINNERS

Grand Prize

 DeepRad.AI

Taiwan

Health & Biotech

Funding Stage: pre A Round Founding Year: 2023
Looking for
image of

image of

image of

Product/Solution

DeepLung-CAC

DeepLung-CAC automatically detects lung nodules, predicts coronary artery calcification risk, and assesses bone density risk using a single set of low-dose chest CT scans. With just one click, it generates a comprehensive report that increases radiologists' efficiency. DeepLung-CAC effectively enhances the efficiency and effectiveness of radiologists and screening processes, providing patients with early diagnostic opportunities for these three conditions and reducing both individual and societal healthcare burdens.

Company Description

DeepRad.AI utilizes advanced AI and medical imaging technology for early screening and prevention of common diseases in middle-aged and elderly populations.